Gaudenz von Capeller

CFO at Cellestia Biotech
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Basel, Basel, Switzerland, CH

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Switzerland
    • Biotechnology Research
    • 1 - 100 Employee
    • CFO
      • Jul 2017 - Present

      Basel Area, Switzerland Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having… Show more Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland. - Built company structure from sratch - Raised USD 55 Mio in Equity Show less

    • CFO
      • Dec 2012 - Jun 2017

      Basel Area, Switzerland - Built company from scratch - Raised USD 50 Mio equity

    • Board Member
      • Nov 2010 - Dec 2013

      Luxembourg - Manage Real Estate Company - Negotiate Loans with local banks

    • Switzerland
    • Real Estate
    • 1 - 100 Employee
    • CFO
      • Jul 2010 - Dec 2013

      - Prepare IPO at SIX, which led to M&A with Partners Group - Negotiate Loans and Mortgages > USD 300 Mio - Run Finance and HR

    • Switzerland
    • Pharmaceutical Manufacturing
    • 400 - 500 Employee
    • Managing Director
      • Jun 2008 - Feb 2010

      - Lead Swiss Local Management Team - Integration into parent organization post merger

    • Finance Director
      • Jun 2003 - May 2008

      Switzerland - Trade sale to Dishman Pharmaceuticals, India - Turnaround of Swiss Business post CH11 of US Parent

    • United States
    • Software Development
    • 1 - 100 Employee
    • EMEA Controller
      • 1998 - 2003

      - Built European Finance organization - Set up shared service center for 6 legal entities

    • Switzerland
    • Financial Services
    • 700 & Above Employee
    • Controller
      • 1993 - 1998

Education

  • IMD Business School
    2006 - 2006
  • University of Basel
    1990 - 1993
  • Bäumlihof Gymnasium
  • Bäumlihof Gymnasium
  • Hochschule für Wirtschaft FHNW / School of Business FHNW
  • University of Applied Sciences Basel
    Finance and Controlling

Community

You need to have a working account to view this content. Click here to join now